Fractyl Health (GUTS) Insider Ajay Royan Buys $20K of Stock
Ajay Royan purchased 23,000 shares of GUTS for $19,550 on June 12, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Ajay Royan bought 23,000 shares of Fractyl Health, Inc. ($GUTS) at an average price of $0.85, worth about $19,550, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $GUTS is up 2.2% after 1 week, down 10.4% after 1 month and down 84.8% to date (from the $10.20 close on Jun 12, 2026).
Key Points
- Ajay Royan bought 23,000 shares of GUTS at $0.85 each, totaling $19,550 on June 12, 2026.
- Shares of GUTS traded at $0.83, with various institutional investors adjusting their positions.
- Analyst HC Wainwright & Co. reiterated a buy rating with an $8.00 target on June 4, 2026.
Get $GUTS trade alerts by text
We text you when insiders, Congress or big funds trade $GUTS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Fractyl Health, Inc. alert may contain errors. Disclosures
Ajay Royan made a notable purchase of GUTS shares on June 12, 2026. Royan acquired 23,000 shares at a price of $0.85 each, amounting to a total transaction value of $19,550. This insider activity was not part of a pre-planned trading program.
Other Institutional Activity in GUTS
Several institutional investors have also been active in GUTS. Nantahala Capital Management, LLC increased its holdings by 2,518,079 shares, bringing its total to 13,364,519 shares worth approximately $6.12 million. Similarly, 683 Capital Management, LLC added 679,615 shares, ending with 6,727,235 shares valued at about $3.08 million. Pale Fire Capital SE significantly boosted its stake by 2,711,103 shares, holding a total of 5,921,045 shares worth approximately $2.71 million. Vanguard Capital Management LLC now holds 5,533,006 shares valued at $2.53 million, while Catalio Capital Management, LP maintained its position at 5,491,866 shares worth around $2.51 million.
Fractyl Health, Inc. Stock Up 38.8%
Shares of GUTS traded around $0.83. The company has seen varied interest from institutional investors, with some increasing their stakes considerably. The stock's price movements and insider activities are closely watched by investors.
Insider Buying and Selling at Fractyl Health, Inc.
In addition to Ajay Royan's recent purchase, other insiders have been active as well. On June 10, 2026, Kelly Ann Barnes, William Bradley, and Christopher Charles Thompson each acquired 22,500 shares. William Bradley also bought an additional 68,493 shares at $0.73 per share on the same date.
Analysts Set New Price Targets
On June 4, 2026, HC Wainwright & Co. reiterated its buy rating on GUTS, maintaining a price target of $8.00. Canaccord Genuity also maintained a buy rating with the same target. Meanwhile, Morgan Stanley downgraded the stock to hold with a $2.00 price target earlier in the year on January 30, 2026.
Bottom Line
Ajay Royan's recent purchase of GUTS shares adds to the insider activity surrounding the company. Institutional investors have shown varied interest, with some increasing their holdings significantly. Analyst ratings remain optimistic, with HC Wainwright & Co. reiterating a buy rating. As always, it's important to note that insider transactions and 13F filings reflect past actions and may not indicate current positions.
Source: Ajay Royan's Form 4 filing on $GUTS (Jun 12, 2026). Find the original filing: GUTS Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
